过去一年中添加的文章，按日期排序
… AND EFFECTIVENESS AFTER TRANSITION TO A BIOSIMILAR ANTI-TNF IN INFLAMMATORY ARTHRITIS: POPULATION-BASED EVIDENCE FROM A POLICY …
D Lacaille, K Moolooghy, JA Aviña-Zubieta, Y Zheng… - 2024 - ard.bmj.com
38 天前 - … 2019, that current users of etanercept and infliximab for … Methods: We identified
etanercept and infliximab users for … To account for the potential impact of the COVID-19 …
etanercept and infliximab users for … To account for the potential impact of the COVID-19 …
[HTML][HTML] Adverse Events Associated with COVID-19 Pharmaceutical Treatments
M Maglione, JD Klausner, PK Wirnkar, I Fallarme… - 2024 - ncbi.nlm.nih.gov
112 天前 - … by available data on populations hospitalized with specific … Thus, there is insufficient
certainty of evidence for … No studies of anakinra for COVID-19 met our inclusion criteria …
certainty of evidence for … No studies of anakinra for COVID-19 met our inclusion criteria …
[HTML][HTML] MIS-C and Kawasaki disease: Different illnesses or part of the same spectrum?
A Ravelli - Global Pediatrics, 2024 - Elsevier
144 天前 - … During COVID-19 pandemic pediatricians have been … The present article is
aimed to analyze critically the … The IL-1 inhibitor anakinra was often administered in case of …
aimed to analyze critically the … The IL-1 inhibitor anakinra was often administered in case of …
All available clinical data on anakinra in COVID-19: an updated comprehensive review
160 天前 - … We aimed to review the current clinical evidence regarding the therapeutic effects
of … In conclusion this study showed that anakinra may be effective for COVID-19 patients with …
of … In conclusion this study showed that anakinra may be effective for COVID-19 patients with …
Treatment of Adults Hospitalized With COVID-19 Pneumonia
P Mathew, M Feldmann - JAMA, 2023 - jamanetwork.com
217 天前 - … evidence, together with clinical and translational data from an early-phase clinical
trial with infliximab-… Infliximab, off patent, is inexpensive and readily available worldwide with …
trial with infliximab-… Infliximab, off patent, is inexpensive and readily available worldwide with …
Treatment of Adults Hospitalized With COVID-19 Pneumonia—Reply
WG Powderly, L LaVange, SA Bozzette - JAMA, 2023 - jamanetwork.com
217 天前 - … We believe the totality of the evidence supports a conclusion of possible … infliximab
and abatacept are reasonable options for clinical use in patients hospitalized with COVID-19…
and abatacept are reasonable options for clinical use in patients hospitalized with COVID-19…
Adjunctive treatment in COVID-19 and sepsis—What did we learn?
EJ Giamarellos-Bourboulis - Medizinische Klinik-Intensivmedizin und …, 2023 - Springer
237 天前 - … clinical evidence on how the immunotherapy of COVID-19 assisted … (COVID-19),
namely anakinra, baricitinib and tocilizumab as adjunctive treatment to antivirals. The present …
namely anakinra, baricitinib and tocilizumab as adjunctive treatment to antivirals. The present …
Clinical trials approved by Aifa for Covid-19: report of the main results to fill the unmet medical need.
C Confalonieri, A Orcesi, R Lasala… - Recenti Progressi in …, 2023 - europepmc.org
252 天前 - … The protocols available for each clinical study were … updated/registered for Covid-19
indication; anakinra, baricitinib, … have been entered into compassionate use programmes. …
indication; anakinra, baricitinib, … have been entered into compassionate use programmes. …
Monoclonal antibodies in therapy of COVID-19
A Gicheva Pepovska - 2023 - repozitorij.pharma.unizg.hr
271 天前 - … For presenting evidence of the use of new mAbs with … Anakinra has extension of
indication to treat COVID-19 in … - For whom vaccination with any available COVID-19 vaccine, …
indication to treat COVID-19 in … - For whom vaccination with any available COVID-19 vaccine, …